Thursday, July 31, 2025

Xi Jinping re-awarded as Chinese President for a third five-year term

Date:

Beijing: China’s Parliament on Friday unanimously endorsed an unprecedented third five-year term for President Xi Jinping.

Xi, 69, was re-awarded by the once-in-a-five-year Congress of the ruling Communist Party of China (CPC) as its leader in October last year, becoming the first Chinese leader after the party founder Mao Zedong to continue in power beyond the two five-year terms.

China’s legislature, the National People’s Congress (NPC) often described as the rubber stamp Parliament, for its mechanical and routine endorsement of the decisions of the CPC on Friday voted on the expected lines ratifying Xi’s third term.

Xi is widely expected to continue in power for life.

He has already been awarded as the General Secretary of the CPC during its last October Congress, which also selected a new leadership for all its top policy bodies.

This year’s annual session of the NPC is regarded significant as it heralds a once-in-a-ten-year change of leadership of the Chinese government, including the Premier who presides over the State Council, the central Cabinet.

The term of the present Premier Li Keqiang will end with this year’s NPC session.

His successor, widely expected to be Li Qiang, who is a close associate of Xi, is likely to be selected by the NPC on Saturday.

All the names of the new leadership have been approved by the Plenum of the CPC headed by Xi a few weeks ago. The NPC approval is a routine formality.

The new Premier will address the annual press conference on Mar 13, the last day of this year’s annual NPC session.

PTI

Related articles

Maharashtra’s New Social Media Guidelines for Government Employees | Freedom of Speech or Control? | Digital Discipline or Silent Dictatorship?

The Maharashtra government has ordered employees to follow new social media guidelines that ban employees from criticizing currently,...

The Need for Integrative Thinking in Medicine: A Critical Analysis of COVID-19 Vaccine Rollout in India – Dr. Amitav Banerjee

NIMHANS Bengaluru Research Fuels Urgent Call for Critical Appraisal of India’s COVID-19 Vaccine Rollout Amidst Neurological Concerns As India...

Improving Public Education on Cervical Cancer: Dr. Maya Valecha’s Insights

Concerns Surrounding the Cervical Cancer Vaccine in India An article by Dr. Maya Valecha critiques the Indian government's promotion...

Slap on Rhea Chakraborty and sponsored media: Court Issues Notice After CBI Declares Her complaint as False | Media Lie Exposed: No Clean Chit...

In fact, she and sponsored media are going to face prosecution. Reply to be filed before 12th August. In a...